New Technology– category –
-
Claude Mythos Preview Dominates 2026 AI Reasoning Benchmarks with 71.2 Points, Leading Multi-Step Inference Capabilities
LLM Stats Global Overview As of May 2026, AI model rankings for reasoning tasks show Claude Mythos Preview maintaining the lead with 71.2 points, followed by GPT-5.5 (62.5 points) and Claude Opus 4.7 (62.3 points). These benchmarks speci... -
World Action Models: The Next Frontier in Embodied AI Integrating Dynamics and Action Generation
YouTube (arXiv discussion) Global Overview A new survey paper defines and systematically analyzes World Action Models (WAMs) as embodied foundation models integrating world dynamics modeling with action generation. It clearly distinguish... -
Claude Mythos Preview Leads AI Reasoning Benchmarks with 99 Points, Outperforming Competitors in Critical Tasks
BenchLM.ai Global Overview As of May 2026, benchmark data reveals Anthropic's Claude Mythos Preview leading AI reasoning capabilities with a score of 99, followed by Alibaba's Qwen3.7 Max (92 points) and OpenAI's GPT-5.5 (91 points). Rea... -
Sakana AI’s ‘AI Scientist’ Achieves Breakthrough: Autonomous Research Papers Pass Peer Review
AcademicJobs.com Japan Overview Tokyo-based Sakana AI announced a significant breakthrough: its AI Scientist system autonomously generated scientific papers that successfully passed rigorous peer review at a major international machine l... -
Advanced 3D Bioprinting Techniques Drive Progress in Organoid and Tissue Development for Regenerative Medicine and Drug Discovery
News-Medical.Net UK Overview This technical article highlights advancements in 3D bioprinting for creating sophisticated organoid and tissue models, emphasizing their potential for cell therapy, personalized diagnostics, and drug discove... -
Form Bio Launches FormManufacturing: An AI-Driven End-to-End Platform for Genetic Medicine Design and Manufacturing Optimization
Morningstar USA Overview Form Bio has introduced FormManufacturing™, an AI-driven, end-to-end platform for predicting, optimizing, and monitoring manufacturability of genetic medicines, debuting with an AAV-focused offering. Integrating ... -
AIST Develops Novel Culture Media Analysis Technology Using Multifluorescent Polymers and AI, Revolutionizing Biomanufacturing Quality Control
AFPBB News Japan Overview Japan's National Institute of Advanced Industrial Science and Technology (AIST) has developed a novel analytical technology to assess the quality of cell culture media and supplements, critical for biomanufactur... -
Ajinomoto Develops Novel Culture Medium Supplement to Boost Gene Therapy Drug Productivity, Accelerating Biomanufacturing Efficiency
味の素株式会社 IRニュース Japan Overview Ajinomoto Group, in collaboration with its U.S. subsidiary Forge Biologics (acquired in 2023 for ~¥82.8 billion), has developed a novel culture medium supplement designed to significantly enhance ... -
South Korea Approves First ‘Pre-Approval Therapy’ Plan for Advanced Regenerative Medicine, Significantly Broadening Patient Access
Newsweek Japan South Korea Overview South Korea's government has approved its inaugural advanced regenerative medical treatment plan under a groundbreaking 'pre-approval therapy' framework, allowing critically ill patients access to cutt... -
Cytiva’s ELEVECTA Cell Line Receives FDA AMT Designation, Pioneering Next-Gen AAV Manufacturing with 99% Host Cell DNA Reduction
BioPharma BoardRoom USA Overview Cytiva, a Danaher company, has secured FDA Advanced Manufacturing Technology (AMT) designation for its ELEVECTA transient cell line, designed for adeno-associated virus (AAV) manufacturing. This pioneerin...
